Global Cord Blood Corporation
Simbolis: CO
NYSE
2.9876
USDRinkos kaina šiandien
5.2326
P/E santykis
-0.0019
PEG koeficientas
400.08M
MRK kapitalizacija
- 0.00%
DIV pajamingumas
Global Cord Blood Corporation (CO) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 6661 | 6075.8 | 5473.4 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.net-receivables | 0 | 161.3 | 130.3 | 104.3 | ||||||||||||||||
balance-sheet.row.inventory | 0 | 45.9 | 44.3 | 43.8 | ||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 11.9 | 47.8 | 44.8 | ||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 6935 | 6298.1 | 5666.2 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 476.7 | 503.7 | 527.2 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 83.6 | 88.2 | 92.8 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 83.6 | 88.2 | 92.8 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 282.3 | 307 | 290.4 | ||||||||||||||||
balance-sheet.row.tax-assets | 0 | 60.8 | 55.8 | 50.7 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 696.2 | 653.4 | 592.5 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1599.5 | 1608.2 | 1553.7 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 0 | 8534.5 | 7906.3 | 7219.9 | ||||||||||||||||
balance-sheet.row.account-payables | 0 | 8.3 | 9.5 | 20 | ||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 0.1 | 1.6 | 1.7 | ||||||||||||||||
balance-sheet.row.tax-payables | 0 | 31.2 | 29.5 | 32.3 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0.1 | 1.8 | ||||||||||||||||
Deferred Revenue Non Current | 0 | 2473.5 | 2392.9 | 2289.8 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 179.8 | 166 | 146.3 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 3003 | 2891.4 | 2760.6 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0.1 | 1.8 | 3.5 | ||||||||||||||||
balance-sheet.row.total-liab | 0 | 3649.6 | 3517.9 | 3331.4 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | ||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 2887.3 | 2386.2 | 1877.9 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -106.8 | -103.2 | -94.7 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2098.8 | 2098.8 | 2098.8 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 4879.3 | 4381.9 | 3882.1 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 8534.5 | 7906.3 | 7219.9 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 5.7 | 6.6 | 6.4 | ||||||||||||||||
balance-sheet.row.total-equity | 0 | 4885 | 4388.5 | 3888.5 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||
Total Investments | 0 | 282.3 | 307 | 290.4 | ||||||||||||||||
balance-sheet.row.total-debt | 0 | 0.1 | 1.8 | 3.5 | ||||||||||||||||
balance-sheet.row.net-debt | 0 | -6660.8 | -6074 | -5469.9 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 509.5 | 516.2 | 477.7 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 47.9 | 49.1 | 49.4 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 3.2 | -7.2 | -7.2 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 11.7 | 37.6 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -3.8 | 58.3 | 64.1 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | -102.9 | -120.4 | -86.9 | ||||||||||||||||
cash-flows.row.inventory | 0 | -5.3 | -6.8 | -24.1 | ||||||||||||||||
cash-flows.row.account-payables | 0 | -1.1 | -10.5 | -13.6 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | 105.7 | 196.1 | 188.6 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 56.7 | 2.6 | 2.3 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -19.8 | -20.9 | -24.2 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -340 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 210 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0.2 | 0.8 | 8.2 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -19.6 | -20.1 | -146.1 | ||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -7.7 | -6.1 | -4 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -7.7 | -6.1 | -4 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -1.1 | -2.1 | 1.6 | ||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 585.2 | 602.4 | 475.5 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 6661 | 6075.8 | 5473.4 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 6075.8 | 5473.4 | 4997.9 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 613.6 | 630.7 | 624 | ||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -19.8 | -20.9 | -24.2 | ||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 593.8 | 609.8 | 599.8 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1243.3 | 1159.6 | 1221.5 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 183.3 | 178.9 | 189.1 | ||||||||||||||||
income-statement-row.row.gross-profit | 0 | 1059.9 | 980.7 | 1032.3 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 0 | 6.3 | 8.2 | 7.4 | ||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 451.1 | 435.8 | 473.3 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 634.4 | 614.8 | 662.4 | ||||||||||||||||
income-statement-row.row.interest-income | 0 | 32.6 | 30.9 | 25.4 | ||||||||||||||||
income-statement-row.row.interest-expense | 0 | -38.6 | 0 | 0 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 19 | 65.9 | 19.8 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 6.3 | 8.2 | 7.4 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 19 | 65.9 | 19.8 | ||||||||||||||||
income-statement-row.row.interest-expense | 0 | -38.6 | 0 | 0 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 19.9 | -26.8 | 13 | ||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | 0 | 608.9 | 544.9 | 559 | ||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 627.8 | 610.8 | 578.8 | ||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 118.4 | 94.5 | 101.1 | ||||||||||||||||
income-statement-row.row.net-income | 0 | 501.1 | 508.2 | 470.7 |
Dažnai užduodami klausimai
Kas yra Global Cord Blood Corporation (CO) bendras turtas?
Global Cord Blood Corporation (CO) bendras turtas yra 8534525000.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra N/A.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.853.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 4.885.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.403.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.490.
Kas yra Global Cord Blood Corporation (CO) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 501065000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 147000.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 451083000.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 0.000.